Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Larsen

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2013
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT studyL Rostaing, F Vincenti, J Grinyó, et al.
Transplantation|June 30, 1998
Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockadeE T Elwood, C P Larsen, H R Cho, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 15, 2013
Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletionD J Lo, D J Anderson, T A Weaver, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 3, 2011
Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and functionP Thompson, I R Badell, M Lowe, et al.
Immunogenetics|November 15, 2011
Immunogenetic Management Software: a new tool for visualization and analysis of complex immunogenetic datasetsZ P Johnson, R D Eady, S F Ahmad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2011
CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primatesP Thompson, K Cardona, M Russell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 2, 2014
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitorsA D Kirk, A Guasch, H Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2012
Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaquesS K Ramakrishnan, A Page, A B Farris, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2013
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT studyL Rostaing, F Vincenti, J Grinyó, et al.
Transplantation|June 30, 1998
Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockadeE T Elwood, C P Larsen, H R Cho, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 15, 2013
Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletionD J Lo, D J Anderson, T A Weaver, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 3, 2011
Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and functionP Thompson, I R Badell, M Lowe, et al.
Immunogenetics|November 15, 2011
Immunogenetic Management Software: a new tool for visualization and analysis of complex immunogenetic datasetsZ P Johnson, R D Eady, S F Ahmad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2011
CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primatesP Thompson, K Cardona, M Russell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 2, 2014
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitorsA D Kirk, A Guasch, H Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2012
Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaquesS K Ramakrishnan, A Page, A B Farris, et al.
Pageof 13